Safety features protecting consumers against falsified medicines coming into force, says Dutch regulator

The packaging of prescription-only medicinal products must have safety features from February 9, 2019 onwards, the Dutch Medicines Evaluation Board (CBG) has reminded players. The pharmacy can use these features for checking that the medicines are genuine and thereby protect consumers better against possible falsification.

This is stated in the European directive that is intended to prevent falsified medicinal products for human use from getting into the legitimate medicines chain.

Companies, wholesalers and pharmacies now have 18 months in which to modify the packaging of medicinal products.